Glen Eagle Advisors’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15K Sell
130
-316
-71% -$3.29K ﹤0.01% 909
2025
Q4
$5.3K Buy
446
+3
+0.7% +$40 ﹤0.01% 770
2025
Q3
$6.25K Buy
443
+185
+72% +$2.34K ﹤0.01% 761
2025
Q2
$2.5K Buy
258
+83
+47% +$934 ﹤0.01% 821
2025
Q1
$2.23K Hold
175
﹤0.01% 834
2024
Q4
$3.61K Hold
175
﹤0.01% 789
2024
Q3
$2.47K Hold
175
﹤0.01% 876
2024
Q2
$2.19K Hold
175
﹤0.01% 886
2024
Q1
$2.32K Buy
175
+24
+16% +$372 ﹤0.01% 888
2023
Q4
$2.86K Hold
151
﹤0.01% 820
2023
Q3
$2.27K Hold
151
﹤0.01% 842
2023
Q2
$3.26K Sell
151
-17
-10% -$464 ﹤0.01% 799
2023
Q1
$4.73K Sell
168
-1
-0.6% -$28 ﹤0.01% 724
2022
Q4
$4.27K Hold
169
﹤0.01% 736
2022
Q3
$4.87K Sell
169
-4
-2% -$118 ﹤0.01% 710
2022
Q2
$4.38K Buy
+173
New +$4.99K ﹤0.01% 733

Other funds holding EMBC

Glen Eagle Advisors's EMBC Position: Q1 2026 in Review

Glen Eagle Advisors reduced its Embecta (EMBC) stake by 71% in Q1 2026, selling an estimated $3.29K and leaving 130 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Glen Eagle Advisors first reported a position in EMBC in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.25K in Q3 2025. 337 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • Glen Eagle Advisors held 130 shares of Embecta worth $1.15K as of Q1 2026.
  • Glen Eagle Advisors sold 316 Embecta shares in Q1 2026, an estimated $3.29K.
  • Embecta made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #909 holding.
  • Glen Eagle Advisors first reported a position in Embecta in Q2 2022 and has held it in 16 quarters since.
  • Glen Eagle Advisors's Embecta position peaked at $6.25K in Q3 2025.
  • 337 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.